Losartan may inhibit the progression of liver fibrosis in chronic HCV patients

BACKGROUND: Abundant experimental evidence indicates overproduction of angiotensin II in the injured liver, and a role in stimulation of hepatic stellate cell (HSC) activation and fibrogenesis thereby, representing an attractive antifibrotic target. The aim of this study was to examine the antifibro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatobiliary Surg Nutr
Main Authors: Salama, Zakaria A., Sadek, Ahmed, Abdelhady, Ahmed M., Darweesh, Samar Kamal, Morsy, Shereif Ahmed, Esmat, Gamal
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4876242/
https://ncbi.nlm.nih.gov/pubmed/27275467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/hbsn.2016.02.06
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados